Hbm Holdings Ltd
HKEX:2142
Hbm Holdings Ltd
Cash from Financing Activities
Hbm Holdings Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Cash from Financing Activities
$70.6m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Cash from Financing Activities
HK$2.9m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Cash from Financing Activities
HK$4.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Cash from Financing Activities
-HK$596.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Essex Bio-Technology Ltd
HKEX:1061
|
Cash from Financing Activities
-HK$309.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Hbm Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
70.6m
USD
Based on the financial report for Dec 31, 2023, Hbm Holdings Ltd's Cash from Financing Activities amounts to 70.6m USD.
What is Hbm Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-6%
Over the last year, the Cash from Financing Activities growth was 0%. The average annual Cash from Financing Activities growth rates for Hbm Holdings Ltd have been -42% over the past three years , -6% over the past five years .